A novel Mitomycin C-Triamcinolone conjugate for the prevention of proliferative vitreoretinopathy: In-vitro efficacy and rat retinal toxicity

EVRS Educational Electronic Journal

Volumn 1, Issue 5, 2005, Pages 18-27

  Macky, Tamer A ^a,b,c   Soliman, Mahmoud M ^a,b   Oelkers, Carsten ^a,b   Heredia, Martin L ^a,b   Künzel, Eva ^a,b   Baerbel, Rohrer ^a,b   Crosson, Craig E ^a,b   Rohr, Jürgen ^a,b  

^a CAIRO UNIVERSITY   (Egypt)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c NONE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; GLUTARIC ACID; MITOMYCIN C; MITOMYCIN C PLUS TRIAMCINOLONE; PHOSPHATE; PROPYLENE GLYCOL; TRIAMCINOLONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DRUG CONJUGATION; DRUG EFFICACY; DRUG EXPOSURE; DRUG HALF LIFE; DRUG HYDROLYSIS; DRUG RESPONSE; DRUG SAFETY; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; FIBROBLAST CULTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; IC 50; IN VITRO STUDY; MITOSIS INHIBITION; MODULATION; NONHUMAN; PH MEASUREMENT; QUANTITATIVE ANALYSIS; RAT; RETINA DISEASE; SENSORY SYSTEM ELECTROPHYSIOLOGY; SLOW RELEASE FORMULATION; VITREORETINOPATHY; WOUND HEALING;

EID: 33746347728     PISSN: 17653169     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Wakaki, S.; Marumo, H.; Tomioka, K.; Shimizu, G.; Kato, E.; Kamada, H.; Kudo, S.; Fujimoto, Y. Isolation of New Fractions of Antitumor Mitomycins. Antibiot. Chemother. 1958, 8, 228-240.
2. Miyamura, S.; Shigeno, N.; Matsui, M.; Wakaki, S.; Uzu, K. The Biological Studies on Mitomycin I. Antibacterial Activities of Mitomycin Derivatives. J. Antibiot. 1967, 20, 72-76.
3. In Goodman & Gilmans's The Pharmacological Basis of Therapeutics, 9th ed.; Hardman, J. G.; Limbird, L. E.; Molinoff, P. B.; Ruddon, R. W.; Gilman, A. G., Eds.; McGraw-Hill: New York, 1996; pp 1268-1269.
4. Beijnen, J. H.; Bult, A.; Underberg, W. J. M. Mitomycin C. Anal Profiles Drug Subs 1986, 16, 361-401.
5. Mao, Y.; Varoglu, M.; Sherman, D. H. Genetic Localization and Molecular Characterization of Two Key Genes (mitAB) Required for Biosynthesis of the Antitumor Antibiotic Mitomycin C. J Bacteriol 1999, 181, 2199-2208.
6. Mao, Y.; Varoglu, M.; Sherman, D. H. Molecular Characterization and Analysis of the Biosynthetic Gene Cluster for the Antitumor Antibiotic Mitomycin C from Streptomyces lavendulae NRRL 2564. J Bacteriol 1999, 181, 2199-2208.
7. Webb, J. S.; Cosulich, D. B.; Mowat, J. H.; Patrick, J. B.; Broschard, R. W.; Meyer, W. E.; Williams, R. P.; Wolf, C. F.; Fulmor, W.; Pidacks, C. The Structures of Mitomycins A, B and C and Porfiromycin-Part I. J Am Chem Soc 1962, 84, 3185-3187.
8. Webb, J. S.; Cosulich, D. B.; Mowat, J. H.; Patrick, J. B.; Broschard, R. W.; Meyer, W. E.; Williams, R. P.; Wolf, C. F.; Fulmor, W.; Pidacks, C. The Structures of Mitomycins A, B and C and Porfiromycin-Part II. J Am Chem Soc 1962, 84, 3187-3188.
9. Stevens, C. L.; Taylor, K. G.; Munk, M. E.; Marshall, W. S.; Noll, K.; Shah, G. D.; Shah, L. G.; Uzu, K. Chemistry and Structure of Mitomycin C J Med Chem 1965, 8, 1-10.
10. Fukuyama, T.; Nakatsubo, F.; Cocuzza, A. J.; Kishi, Y. Synthetic Studies Toward
11. Mitomycins. III. Total Syntheses of Mitomycins A and C. Tetrahedron Lett. 1977, 4295-4298
12. Fukuyama, T.; Yang, L. Practical Total Synthesis of Mitomycin C. J Am Chem Soc 1989, 111, 8303-8304.
13. Verweij, J.; Schellens, J. H. M.; Loo, T. L.; Pinedo, H. M. Antitumor Antibiotics. In Cancer Chemotherapy: Principles and Practice, 2nd ed., Chabner, B. A.; Longo, D. L., Eds. J. B. Lippincott Co: Philadelphia, 1995; pp 395-407.
14. Crooke, S. T. Antitumor Antibiotics II: Actinomycin D, Bleomycin, Mitomycin C and Other Antibiotics. In The Cancer Pharmacology Annual, Chabner B. A.; Pinedo, H. M., Eds. Excerpta Medica: Amsterdam, 1983; pp 69-79.
15. Szybalsky, W.; Iyer, V. N. Crosslinking of DNA by Enzymatically or Chemically Activated Mitomycins and Porfiromycins, Bifunctionally Alkylating "Antibiotics." Feder Proc 1964, 23, 946-957.
16. Sastry, M.; Fiala, R.; Lipman, R.; Tomasz, M.; Patel, D. J. Solution Structure of the Monoalkylated Mitomycin C-DNA Complex. J Mol Biol 1995, 247, 338-359.
17. Sartorelli, A. C.; Hodnick, W. F.; Belcourt, M. F.; Tomasz, M.; Haffty, B.; Fischer, J. J.; Rockwell, S. Mitomycin C: A Pprototype Bbioreductive Agent. Oncol Res 1994, 6, 501-508.
18. Tomasz, M. Mitomycin C: Small, Fast and Deadly (but very selective). Chem Biol 1995, 2, 575-579.
19. Dorr, R. T. New Findings in the Pharmacokinetics, Metabolic, and Drug-Resistance Aspects of Mitomycin C. Semin Oncol 1988, 15 Suppl. 4, 32-41.
20. Mahar, P. S.; Nwokora, G. E. Role of Mitomycin C in Pterygium Surgery. Br J Ophthalmol 1993, 77, 433-435.
21. Hilton, G.; Machemer, R.; Michels, R.; Okun, E.; Schepens, C.; Schwartz, A. The Classification of Retinal Detachment with Proliferative Vitreoretinopathy. Ophthalmol 1983, 90, 121-125.
22. Rachal, W. F.; Burton, T. C. Changing Concepts of Failures After Retinal Detachment Surgery. Arch Ophthalmol 1979, 97, 480-483.
23. Sternberg Jr., P.; Machemer, R. Results of Conventional Vitreous Surgery for Proliferative Vitreoretinopathy, Am J Ophthalmol 1985, 100, 141-146.
24. Aaberg, T. M. Management of Anterior and Posterior Proliferative Vitreoretinopathy. Am J Ophthalmol 1988, 106, 519-532.
25. Lewis, H.; Aaberg, T. M.; Abrams, G. W. Causes of Failure After Initial Vitreoretinal Surgery for Severe Proliferative Vitreoretinopathy. Am J Ophthalmol 1991, 111, 8-14.
26. Lewis, H.; Aaberg, T. M. Causes of Failure After Repeat Vitreoretinal Surgery for Recurrent Proliferative Vitreoretinopathy. Am J Ophthalmol 1991, 111, 15-19.
27. Campochiaro, P. A.; Kaden, I. H.; Vidaurri-Leal, J.; Glaser, B. M. Cryotherapy Enhances Intravitreal Dispersion of Viable Retinal Pigment Epithelial Cells. Arch Ophthalmol 1985, 103, 434-436.
28. Stern, W. H.; Lewis, G. P.; Erickson, P. A.; Guerin, C. J.; Anderson, D. H.; Fisher, S. K.; O'Donnell, J. J. Fluorouracil Therapy for Proliferative Vitreoretinopathy after Vitrectomy. Am J Ophthalmol 1983, 96, 33-42.
29. Borhani, H.; Peyman, G. A.; Rahimy, M. H.; Thompson, H. Suppression of Experimental Proliferative Vitreoretinopathy by Sustained Intraocular Delivery of 5-FU. Int Ophthalmol 1995, 19, 43-49.
30. Ruhmann, A.; Berliner, D. Effect of Steroids on Growth of Mouse Fibroblasts In Vitro. Endocrinology 1965, 76, 916-927.
31. Charteris, D. G.; Hiscott, P.; Grierson, I.; Lightman, S. L. Proliferative Vitreoretinopathy: Lymphocytes in Epiretinal Membranes. Ophthalmology 1992, 99, 1364-1367.
32. Charteris, D. G.; Hiscott, P.; Robey, H. L.; Gregor, Z. J.; Lightman, S. L.; Grierson, I. Inflammatory Cells in Proliferative Vitreoretinopathy Subretinal Membranes. Ophthalmology 1993, 100, 43-46.
33. Little, B. C.; Limb, G. A.; Meager, A.; Ogilvie, J.A.; Wolstencroft, R.A.; Fraks, W.A.; Chignell, A.H.; Dumonde, D.C. (abstract) Cytokines in Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci 1991, 32, 768.
34. Limb, G. A.; Little, B. C.; Meager, A; Ogilvie, J.A.; Wolstencroft, R.A.; Fraks, W.A.; Chignell, A.H.; Dumonde, D.C. Cytokines in Proliferative Vitreoretinopathy. Eye 1991, 5, 686-693.
35. Schleimer, R. P. An Overview of Glucocorticoids Anti-inflammatory Actions. Eur J Clin Pharmacol 1993, 45, S3-S7.
36. Lee, S. W.; Tsou, A. P.; Chan, H.; Thomas, J.; Petrie, K.; Eugui, E.M.; Allison A.C. Glucocorticoids Selectively Inhibit the Transcription of the Interleukins 1B Gene and Decrease the Stability of Interleukins 1B mRNA. Proc Natl Acad Sci USA 1988, 85, 1204-1208.
37. Arya, S. K.; Wong-Staal, F.; Gallo, R. C. Dexamethasone-Mediated Inhibition of Human T-cell Growth Factor and Gamma Interferon Messenger RNA. J Immunol 1984, 133, 273-276.
38. Berger, A. S.; Cheng, C.-K.; Pearson, P. A.; Ashton, P.; Crooks, P. A.; Cynkowsky, T.; Cynkowska, G.; Jaffe, G. J. Intravitreal Sustained Release Corticosteroid-5-Fluoruracil Conjugate in the Treatment of Experimental Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci 1996, 37, 2318-2325.
39. Yu, H. G.; Chung, H. Antiproliferative Effect of Mitomycin C on Experimental Proliferative Vitreoretinopathy in Rabbits. Korean J Ophthalmol 1997, 11, 98-105.
40. Chandler, D. B.; Rozakis, G.; Dejaun, E.; Machemer, R. The Effect of Triamcinolone Acetonide on Refined Experimental Model of Proliferative Vitreoretinopathy. Am J Ophthalmol 1985, 99, 686-690.
41. Chandler, D. B.; Hida, T.; Sheta, S.; Proia, A. D.; Machemer, R. Improvement in Efficacy of Corticosteroid Therapy in an Animal Model of Proliferative Vitreoretinopathy by Pretreatment. Graefe's Arch Clin Exp Ophthalmol 1987, 225, 259-265.
42. Sunalp, M.; Weidemann, P.; Sorgente, N.; Ryan, S. J. Effects of Cytotoxic Drugs on Proliferative Vitreoretinopathy in the Rabbit Cell Injection Model. Curr Eye Res 1984, 3, 619-623.
43. Staab, H. A. Synthesen mit Heterocyclischen Amiden (Azoliden). Angew Chem 1962, 74, 407-423.
44. Blumenkranz, M. S.; Claflin, A.; Hajek, A. S. Selection of Therapeutic Agents for Intraocular Proliferative Disease. Arch Ophthalmol 1984, 102, 589.
45. Blumenkranz, M. S.; Hartzer, M. K.; Hajek, A. S. Selection of Therapeutic Agents for Intraocular Proliferative Disease. Arch Ophthalmol 1987, 105, 396-399.
46. Bernstein, S.; Lenhard, R. H.; Allen, W. S.; Heller, M.; Littell, R.; Stolar, S. M.; Feldman, L. I.; Blank, R. H. 16-Hydroxylated Steroids. VI. The Synthesis of the 16α-Hydroxy Derivatives of 9α-Substituted Steroids. J Am Chem Soc 1959, 81, 1689-1696.
47. In Organikum, 18th ed.; Deutscher Verlag der Wissenschaften: Berlin, 1990, pp 396-408.
48. Berger, A. S.; Cheng, C. K.; Pearson, P. A.; Ashton, P.; Crooks, P. A.; Cynkowski, T.; Cynkowska, G.; Jaffe, G. Intravitreal Sustained Release Corticosteroid-5-Fluoruracil Conjugate in the Treatment of Experimental Proliferative Vitreoretinopathy. Invest Ophthalmol Vis Sci 1996, 37, 2318-2325.
49. Ishiki, N.; Onishi. H.; Machida, Y. Biological Properties of Conjugates of Mitomycin C with Estradiol Benzoate and Estradiol: Ttheir Stability Characteristics in Biological Media and Their Binding Abilities to Estrogen Receptor. Biol Pharm Bull 1997, 20, 1096-1102.
50. Ishiki, N.; Onishi, H.; Machida, Y. Conversion Characteristics of the Conjugates of Mitomycin C with Estradiol and Estradiol Benzoate in Various pH Media. Chem Pharm Bull 1997, 45, 1345-1349.
51. Ishiki, N.; Onishi, H.; Machida, Y. In Vivo Properties of the Conjugategs of Mitomycin C with Estradiol Benzoate and Estradiol: Pharmacokinetics and Antitumor Characteristics Against P388 Leukemia and Sarcoma 180, Biol Pharm Bull 1998, 21, 1180-1186.
52. Lyubarsky, A.L.; Pugh, E.N. Jr. Recovery Phase of the Murine Rod Photoresponse Reconstructed from Electroretinographic Recordings. J Neurosci 1996, 16, 563-571.
53. Rohrer, B.; Korenbrot, J.; LaVail, M.M.; et al. Role of Neurotrophin Receptor TrkB in the Maturation of Rod Photoreceptors and Establishment of Synaptic Transmission to the Inner Retina. J Neurosci 1999, 196, 8919-8930.